RxDoctor Payments Data

Claire Murphy, MD

Anatomic Pathology & Clinical Pathology · Springfield, ORNPI 1427314665

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $17,430 of the $19,771 with a category attached, or 88.2%. AstraZeneca accounts for 97.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $12,726 and has fallen 50.2% since, to $6,336 in 2025. Among anatomic pathology & clinical pathology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,771in general payments, 2019–2025

Across 33 payments — averaging $599.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$19K
  • Merck$191
  • Genentech USA, Inc.$186
  • Sanofi$50
  • Blueprint Medicines Corporation$24
  • Janssen Scientific Affairs, LLC$18
  • plus $15 from 1 others

What the payments were for

  • Speaking & faculty fees$17,43088%
  • Travel & lodging$1,2346%
  • Food & beverage$1,1076%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,771 in reported general payments places this provider in the 95th percentile of 71 anatomic pathology & clinical pathology providers in Oregon.

See all anatomic pathology & clinical pathology providers in Oregon

Medicare billing

Part B allowed, 2024
$168,655
Medicare patients
754
Services billed
5,284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Springfield

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →